Devyser Diagnostics AB (FRA:OL0) achieves its first profitable quarter with a 41.5% revenue increase, driven by strong partnerships and operational efficiency.

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

Thermo Fisher Scientific has launched the Invitrogen Evos S1000 spatial imaging system, which enables researchers to produce ...

This was the stock's fifth consecutive day of losses.

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

We recently published a list of 10 Best Manufacturing Stocks To Buy Now. In this article, we are going to take a look at ...

The lab equipment maker expects adjusted profit between $2.17 and $2.25 per share, below analysts' average estimate of $2.42 ...

Shares of Thermo Fisher Scientific Inc. TMO slid 1.38% to $545.23 Tuesday, on what proved to be an all-around favorable ...

LOGAN — Utah State University (USU) is playing a crucial role in shaping Northern Utah’s economic landscape, serving as a ...

A local hospital is making an effort to help transport infants to the hospital. UPMC Hamot is providing ambulances throughout ...